Selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors in pregnancy: Infant and childhood outcomes

Synthèse documentaire ASEM

Document officiel de Canadian Paediatric Society (2021) sur « Selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors in pregnancy: Infant and childhood outcomes ». Extrait officiel (langue source) : This position statement provides guidance for the monitoring, care, and follow-up of newborns exposed to selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) in utero. Depression and anxiety are common during pregnancy and postpartum. While there are risks to taking medications during pregnancy, untreated or incompletely managed depression and anxiety also carry risk. Consultez la publication officielle pour les recommandations détaillées et leur champ d’application.

Cette synthèse facilite le repérage du document. Pour les recommandations cliniques, consultez toujours la version officielle et sa date de mise à jour.